Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-12-003271
Accepted
2012-11-16 00:15:15
Documents
1
Effectiveness Date
2012-11-15
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-12-003271.txt   1674
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: EFFECT | Act: 33 | File No.: 333-184091 | Film No.: 121210017
SIC: 2834 Pharmaceutical Preparations